PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a ...

Andrew Kress, CEO of HealthVerity, emphasized the transformative impact of RWD on clinical trials, stating that access to extensive real-world data allows companies like Recursion to make informed ...